Medicinova (MNOV) Net Income (2010 - 2026)
Medicinova (MNOV) posted quarterly Net Income of -$2.8 million for Q4 2025, up 15.18% year-over-year from -$2.4 million in Q4 2024, and up 13.1% quarter-over-quarter from -$3.2 million in Q3 2025.
Medicinova (MNOV) Net Income (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Net Income for 16 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Income rose 15.18% year-over-year to -$2.8 million; the TTM figure through Dec 2025 stood at -$12.9 million (down 5.42% YoY), while the FY2025 annual figure was -$9.5 million, up 21.38% from the prior year.
- Net Income climbed to -$2.8 million in Q4 2025 per MNOV's latest filing, from -$3.2 million in the prior quarter.
- Across five years, Net Income topped out at -$226526.0 in Q1 2021 and bottomed at -$85.4 million in Q4 2023.
- Historically, Net Income has averaged -$7.3 million across 5 years, with a median of -$3.2 million in 2023.
- Annual changes were most pronounced in 2021 — Net Income jumped 99.68% — and 2023, when it plunged 2946.46%.
- Medicinova's Net Income stood at -$2.5 million in 2021, then retreated by 12.62% to -$2.8 million in 2022, then slumped by 2946.46% to -$85.4 million in 2023, then surged by 96.14% to -$3.3 million in 2024, then grew by 15.18% to -$2.8 million in 2025.
- Business Quant data shows MNOV's Net Income at -$2.8 million in Q4 2025, -$3.2 million in Q3 2025, and -$3.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | -2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.43 Mn |
| Dec 31, 2025 | -2.79 Mn |
| Sep 30, 2025 | -3.21 Mn |
| Jun 30, 2025 | -3.61 Mn |
| Mar 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -3.17 Mn |
| Mar 31, 2024 | -2.82 Mn |
| Dec 31, 2023 | -85.42 Mn |
| Sep 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -3.06 Mn |
| Mar 31, 2023 | -3.22 Mn |
| Dec 31, 2022 | -2.80 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.18 Mn |
| Mar 31, 2022 | -3.58 Mn |
| Dec 31, 2021 | -2.49 Mn |
| Sep 30, 2021 | -4.67 Mn |
| Jun 30, 2021 | -4.34 Mn |